GlassScriptPhysician profile
Gary A Brunvoll
NPI 1053488353
$11,334.33
in general payments reported to CMS, 2019-2025
31 companies · $4,114 in 2025
The $4,114 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,016 · 2020: $307 · 2021: $373 · 2022: $712 · 2023: $684 · 2024: $4,129 · 2025: $4,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,800 · Food and Beverage: $2,127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,800.00 |
| Food and Beverage | $2,126.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $6,800.00 | 2024-2025 | Bovine Collagen |
| Intuitive Surgical, INC. | $713.60 | 2019 | |
| Astellas Pharma US INC | $589.15 | 2020-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $334.50 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Sage Therapeutics, LLC | $273.14 | 2023-2025 | Zurzuvae |
| Daiichi Sankyo INC. | $254.26 | 2019-2024 | Injectafer |
| Amgen INC. | $240.77 | 2020-2021 | |
| Novo Nordisk INC | $225.25 | 2019-2025 | Wegovy |
| Mayne Pharma Commercial LLC | $194.99 | 2022-2025 | |
| Aspira Women'S Health INC | $167.56 | 2022 | |
| Sumitomo Pharma America, INC. | $151.08 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $145.84 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $139.38 | 2019-2024 | Gardasil 9, Gardasil |
| Caldera Medical, INC | $138.75 | 2024 | Desara |
| Organon LLC | $118.64 | 2021-2024 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Women'S Health, INC. | $104.50 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $103.40 | 2025 | Airsupra |
| Hologic Sales and Service, LLC | $81.56 | 2020-2025 | Myosure Tissue Removal Device, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Pfizer INC. | $77.65 | 2022-2025 | |
| Channel Medsystems, INC. | $73.32 | 2022 | |
| Therapeuticsmd, INC. | $63.98 | 2019-2022 | |
| Myovant Sciences INC. | $57.14 | 2021-2022 | |
| Exeltis, USA INC. | $52.68 | 2020-2025 | Slynd |
| Lilly USA, LLC | $46.20 | 2023 | Mounjaro |
| Shield Therapeutics INC | $33.58 | 2023-2024 | Accrufer |
| Scynexis, INC. | $32.35 | 2022 | |
| Smith+Nephew, INC. | $27.61 | 2021-2025 | Pico |
| Evofem Biosciences, INC. | $27.19 | 2020-2021 | |
| Millicent US INC | $24.82 | 2025 | Intrarosa, Femlyv |
| Lupin INC. | $23.17 | 2020 | |
| Supernus Pharmaceuticals, INC. | $18.27 | 2025 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Brunvoll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.